drugset
drugset / Trial / NCT05380154

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

NCT05380154 ↗

Phase 3 Completed 500 enrolled Hugel Sihuan Pharmaceutical Holdings Group Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a phase 3 clinical trial of multi-center, random, blinded\*, parallel control, and positive control to evaluate the efficacy and safety of Botulax® Injection compared to BOTOX® for improving moderate to severe glabellar wrinkles.

Timeline

Start
2017-05-09
Primary completion
2018-01-22
Completion
2018-07-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 4 iu Other
Subject letibotulinumtoxinA Protein / enzyme biologic 4 iu Other

Indications

No indication recorded.